Radiomics
PrivateLast Round
Grant
Apr 7, 2023
Total Funding Raised
$9.27M
Company Overview
Radiomics operates in Healthcare & Life Sciences and is based in Liège. Its latest recorded funding round was a Grant round in April 2023.
Radiomics is a biotechnology company providing an AI-powered medical imaging and advanced statistics platform to optimize the development of new oncology treatments for biotech and pharma companies.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical Imaging, Medical AI, Healthcare Analytics, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Radiomics Comparables
Compare Radiomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Image Analysis Group | 85% | |
| Altis Labs | 85% | |
| Onc.ai | 78% |
For institutional investors. Book with your work email.
Radiomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 7, 2023 | ||||
| Series A | Nov 17, 2021 | ||||
| Seed | Feb 20, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Radiomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Public service of Wallonia | Grant |
| Noshaq | Seed, Series A |
| Epimede | Series A |
| LeanSquare | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 16, 2025
AI model to predict interstitial lung disease in collaboration with AstraZeneca.
- Oct 16, 2025
Exploring AI model to predict interstitial lung disease related to cancer treatment.
For institutional investors. Book with your work email.
Radiomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Radiomics's valuation, stock price, and market status.
Is Radiomics a public or private company?
Radiomics is a private company.
What is the current stock price of Radiomics?
Radiomics is a private company, so its shares have no public market price. Caplight tracks Radiomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Radiomics worth (valuation)?
Valuation information for Radiomics is not publicly available.
Can I buy Radiomics stock?
Radiomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Radiomics's last funding round?
Radiomics's most recent funding round was Grant on April 7, 2023.
Who are the main investors in Radiomics?
Key investors in Radiomics include Noshaq, Epimede.
Will Radiomics IPO soon?
No public IPO plans have been announced for Radiomics.
How can I track Radiomics secondary market activity?
Caplight tracks bids, offers, and trades in Radiomics's shares on secondary markets.